{"pmid":32282972,"title":"COVID-19: Thoughts and comments from a Tertiary Liver Transplant Center in France.","text":["COVID-19: Thoughts and comments from a Tertiary Liver Transplant Center in France.","We read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al.(1) . Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs.","Am J Transplant","Tzedakis, Stylianos","Jeddou, Heithem","Houssel-Debry, Pauline","Sulpice, Laurent","Boudjema, Karim","32282972"],"abstract":["We read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al.(1) . Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs."],"journal":"Am J Transplant","authors":["Tzedakis, Stylianos","Jeddou, Heithem","Houssel-Debry, Pauline","Sulpice, Laurent","Boudjema, Karim"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282972","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15918","source":"PubMed","weight":0,"locations":["China","France","France"],"countries":["China","France"],"countries_codes":["CHN|China","FRA|France"],"_version_":1663989232528523264,"score":7.979339,"similar":[{"pmid":32277387,"title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-nCoV","COVID-19","Liver transplantation","Management"],"source":"PubMed","locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1663798882904047616,"score":162.03435},{"pmid":32270388,"title":"Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","text":["Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data.","Hepatol Int","Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh","32270388"],"abstract":["The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data."],"journal":"Hepatol Int","authors":["Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270388","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10041-1","source":"PubMed","locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1663620083099893760,"score":157.72243},{"pmid":32246576,"title":"Liver transplantation in an ICU dominated by COVID-19.","text":["Liver transplantation in an ICU dominated by COVID-19.","The Letter from D'Antiga L about concerns of transplanting patients in the context of COVID19 pandemic is very interesting [1]. COVID-19 designates the infection caused by the SARS-Cov2 virus. This illness originated in December, 2019, in Wuhan, China. Since then, it has been identified in more than 150 countries. The first case of COVID-19 in Portugal was notified in March 02, 2020.","Liver Transpl","Cardoso, Filipe S","32246576"],"abstract":["The Letter from D'Antiga L about concerns of transplanting patients in the context of COVID19 pandemic is very interesting [1]. COVID-19 designates the infection caused by the SARS-Cov2 virus. This illness originated in December, 2019, in Wuhan, China. Since then, it has been identified in more than 150 countries. The first case of COVID-19 in Portugal was notified in March 02, 2020."],"journal":"Liver Transpl","authors":["Cardoso, Filipe S"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246576","week":"202014|Mar 30 - Apr 05","doi":"10.1002/lt.25770","keywords":["coronavirus","liver failure","transplant"],"source":"PubMed","locations":["Wuhan","China","Portugal"],"countries":["Portugal","China"],"countries_codes":["PRT|Portugal","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352135821033473,"score":138.7513},{"pmid":32277591,"title":"Fatal outcome in a liver transplant recipient with COVID-19.","text":["Fatal outcome in a liver transplant recipient with COVID-19.","Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation. We describe a case of COVID-19 in a patient who had transplantation three years previously for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multi-organ failure. Despite multiple invasive procedures and rescue therapies, he succumbed to the disease. The management of COVID-19 in the post-transplant setting presents complex challenges emphasizing the importance of strict prevention strategies.","Am J Transplant","Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua","32277591"],"abstract":["Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation. We describe a case of COVID-19 in a patient who had transplantation three years previously for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multi-organ failure. Despite multiple invasive procedures and rescue therapies, he succumbed to the disease. The management of COVID-19 in the post-transplant setting presents complex challenges emphasizing the importance of strict prevention strategies."],"journal":"Am J Transplant","authors":["Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277591","week":"202015|Apr 06 - Apr 12","doi":"10.1111/ajt.15909","keywords":["COVID-19","liver","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663798882972205057,"score":134.3737},{"pmid":32282992,"title":"Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce healthcare resources in transplant allocation decisions.","text":["Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce healthcare resources in transplant allocation decisions.","The novel Coronavirus disease 2019 (COVID-19) is impacting transplant programs around the world, and, as the center of the pandemic shifts to the United States, we have to prepare to make decisions about which patients to transplant during times of constrained resources. In this paper, we discuss how to transition from the traditional justice versus utility consideration in organ allocation to a more nuanced allocation scheme based on ethical values that drive decisions in times of absolute scarcity. We recognize that many decisions are made based on the practical limitations that transplant programs face, especially at the extremes. As programs make the transition from a standard approach to a resource constrained approach to transplantation, we utilize a framework for ethical decisions in settings of absolutely scarce resources to help guide programs in deciding which patients to transplant, which donors to accept, how to minimize risk, and how to ensure the best utilization of transplant team members.","Am J Transplant","Wall, Anji E","Pruett, Timothy","Stock, Peter","Testa, Giuliano","32282992"],"abstract":["The novel Coronavirus disease 2019 (COVID-19) is impacting transplant programs around the world, and, as the center of the pandemic shifts to the United States, we have to prepare to make decisions about which patients to transplant during times of constrained resources. In this paper, we discuss how to transition from the traditional justice versus utility consideration in organ allocation to a more nuanced allocation scheme based on ethical values that drive decisions in times of absolute scarcity. We recognize that many decisions are made based on the practical limitations that transplant programs face, especially at the extremes. As programs make the transition from a standard approach to a resource constrained approach to transplantation, we utilize a framework for ethical decisions in settings of absolutely scarce resources to help guide programs in deciding which patients to transplant, which donors to accept, how to minimize risk, and how to ensure the best utilization of transplant team members."],"journal":"Am J Transplant","authors":["Wall, Anji E","Pruett, Timothy","Stock, Peter","Testa, Giuliano"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282992","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15914","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1663989232708878338,"score":133.82027}]}